MaxQ AI chairman & CEO Gene Saragnese talked to reporter Sarah Faulkner about the company’s software that uses AI to interpret medical images and patient data. Want to see these interviews live? Join us at DeviceTalks. Sarah: Digital health, artificial intelligence and machine learning – these terms represent a lot of the buzz emerging from […]
Boston Scientific aims for personalized Parkinson’s therapy with Vercise DBS
Dr. Rafael Carbunaru and his team at Boston Scientific (NYSE:BSX) have spent the last twenty years building, among other things, the Vercise deep brain stimulation system in an attempt to deliver precise, personalized therapy for people with Parkinson’s disease. “It’s a labor of love,” the VP of R&D told MassDevice.com. Carbunaru estimated there are roughly 1.2 […]
Avoset to develop infusion pump with unnamed pharma giant
Avoset Health said this week that it plans to develop a connected infusion pump with an unnamed pharmaceutical company. The product is set to debut in early 2021. The company touted that its technology allows physicians and pharmacists to track when patients receive infusions, how much drug was infused and which patients need additional intervention. Get […]
Abbott recalls select Ellipse ICDs due to damaged wires
Abbott (NYSE:ABT) began voluntarily recalling 204 Ellipse implantable cardioverter defibrillators in June to prevent the use of devices that may have a vulnerability in the electronic circuitry due to damaged wires, according to a recently-filed urgent field safety notice. The company stressed that it has not received any product performance complaints or adverse patient events related […]
Digirad board approves deal to acquire ATRM Holdings
Digirad Corp. (NSDQ:DRAD) said this week that its board of directors approved a deal to buy ATRM Holdings as a “kick-off” transaction to convert Digirad to a diversified holding company. As part of the acquisition, Digirad plans to create Series A non-convertible, cumulative, perpetual preferred stock with a stated value of $10 apiece. ATRM shareholders are […]
NovaBay raises $2.4m
NovaBay Pharmaceuticals (NYSE:NBY) said this week that it raised $2.4 million in an offering that included three investors. The Emeryville, Calif.-based company has developed products for the eye care market, including a prescription for managing hygiene of the eyelids and lashes. Get the full story at our sister site, Drug Delivery Business News.
Edwards warns on tracking issue reported with Centera TAVR
Edwards Lifesciences (NYSE:EW) issued an urgent field safety notice this week warning customers that it received reports of difficulty tracking and manipulating its Centera TAVR system around the aortic arch. The company said that the issue has caused vascular injury including aortic dissection and death during early cases. The observed incidence of serious events related to […]
Rethinking orthopedic implants with Arthrosurface CEO Steve Ek | DeviceTalks Podcast
Arthrosurface president & CEO Steve Ek talked to reporter Sarah Faulkner about the company’s motion-preserving joint replacement technology. Want to see these interviews live? Join us at DeviceTalks. Sarah: Steve’s office is not your typical corporate office. It’s filled with models of the human skeletal system and demos of the company’s implants. It’s a good […]
Inside Insulet’s pivotal year with CEO Shacey Petrovic
It’s been a busy year at Insulet (NSDQ:PODD). The diabetes tech company welcomed a new CEO, launched its first new product in six years and officially opened its $200 million global headquarters – all in the first half of 2019. That’s all the result of years of rapid growth for Insulet, chief executive Shacey Petrovic said in […]
Axonics wins FDA nod for MR-safe neurostim device in trial
Axonics Modulation Technologies (NSDQ:AXNX) said today that the FDA approved the use of full-body MRI for clinical trial participants implanted with the company’s sacral neuromodulation device. The Irvine, Calif.-based company submitted a supplement to the FDA regarding the use of full-body MRIs in its Artisan-SNM 129-patient pivotal trial. The FDA, which is evaluating Axonics’ device via […]
Zoll acquires TherOx
Zoll Medical said today that it acquired TherOx and its acute myocardial infarction treatment. TherOx’s SuperSaturated Oxygen Therapy system delivers a 60-minute infusion of the patient’s super-oxygenated blood to a targeted ischemic area of the heart via a small catheter. The treatment is designed to improve microvascular flow and reduce infarct size following primary coronary […]
- 1
- 2
- 3
- …
- 251
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube